Activated T lymphocytes in patients with multiple sclerosis.

Area of Science:

• Immunology
• Neuroimmunology
• Cell Biology

Background:

• Multiple Sclerosis (MS) is an autoimmune disease affecting the central nervous system.
• T lymphocytes play a critical role in the immunopathogenesis of MS.
• Identifying activated T lymphocytes can provide insights into disease mechanisms.

Purpose of the Study:

• To investigate the expression of T lymphocyte activation antigens in patients with multiple sclerosis.
• To analyze peripheral blood lymphocytes (PBL) for specific activation markers using monoclonal antibodies.

Main Methods:

• Utilized four monoclonal antibodies (MLR-1, -2, -3, -4) targeting unique determinants on activated T lymphocytes.
• Employed indirect immunofluorescence techniques to detect antigen expression on PBL.
• Analyzed PBL from 20 patients diagnosed with multiple sclerosis (remitting and progressive forms).

Main Results:

• A high percentage of PBL expressed one or more activation antigens in MS patients.
• MLR-2 positive cells were detected in all 20 MS patients, with percentages of 66% (remitting) and 57% (progressive).
• MLR-3, MLR-4, and MLR-1 positive cells showed varying expression levels across patient groups, with observed discrepancies compared to HLA-DR (Ia) antigens.

Conclusions:

• Peripheral blood lymphocytes in multiple sclerosis patients frequently exhibit T lymphocyte activation markers.
• The MLR-2 antigen is consistently expressed on PBL in MS patients, regardless of disease form.
• Further research is warranted to explore the role of these activation antigens and their discrepancies with Ia antigens in MS pathogenesis.